Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GreenLight Biosciences Holdings, PBC - Common Stock
(NQ:
GRNA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 21, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about GreenLight Biosciences Holdings, PBC - Common Stock
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
July 24, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GREENLIGHT BIOSCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GreenLight Biosciences Holdings, PBC - GRNA
May 31, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
GRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of GreenLight Biosciences Holdings, PBC Is Fair to Shareholders
May 30, 2023
From
Halper Sadeh LLC
Via
Business Wire
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
July 20, 2023
Completion of Previously Announced Merger and Going Private Transaction Expected July 20, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 30, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 11, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences Releases Inaugural Sustainability Report
April 12, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
March 30, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
March 09, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
March 07, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
March 01, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
February 01, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
January 09, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
November 09, 2022
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
November 07, 2022
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences announces realignment to focus on near-term value drivers
October 12, 2022
From
GreenLight Biosciences
Via
GlobeNewswire
GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA
October 05, 2022
From
GreenLight Biosciences
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.